Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
Heron Therapeutics (HRTX) PT Lowered to $13 at Cowen
-
Heron Therapeutics (HRTX) PT Lowered to $31 at Cowen, Followinc Clinical Business Update
-
Heron Therapeutics to Present at Several Upcoming Virtual Investor Conferences
-
Heron Therapeutics (HRTX) PT Lowered to $34 at Cowen; Launch Likely Pushed to Mid-2021
-
Heron Therapeutics to Present at the 40th Annual Cowen Healthcare Conference
-
Heron Therapeutics (HRTX) Pricing 8.57M Share Offering at $17.50/Sh
-
Heron Therapeutics Announces Pricing of Public Offering of Common Stock
-
Heron Therapeutics (HRTX) Announces Proposed Common Offering
-
Heron Therapeutics Announces Proposed Public Offering of Common Stock
-
Heron Therapeutics (HRTX) PT Lowered to $40 at Cowen
-
Heron Therapeutics to Present at the 39th Annual Cowen Healthcare Conference
-
Heron Therapeutics (HRTX) PT Raised to $54 at Cowen; Sees HTX-011 as $1B+ Opportunity
-
Pre-Open Movers 06/21: (CASI) (HRTX) (DRI) (KR) Higher; (VERI) (LMNR) (AOBC) Lower (more...)
-
Heron Therapeutics (HRTX) Prices 6M Share Common Offering at $26/Sh
-
Heron Therapeutics Announces Pricing of Underwritten Public Offering of Common Stock
-
Heron Therapeutics (HRTX) to Offer Common Stock
-
Heron Therapeutics Announces Proposed Public Offering of Common Stock
-
Heron Therapeutics (HRTX) PT Raised to $48 at Cowen
-
Heron Therapeutics to Present at the 38th Annual Cowen Healthcare Conference
-
Heron Therapeutics (HRTX): Second Product To Leverage Existing Sales Force - Cowen
-
Heron Therapeutics (HRTX) Sell-Off on Index 'Rebalancing' Creates Buying Opportunity - Cowen
-
Heron Therapeutics to Present at the 37th Annual Cowen and Company Healthcare Conference
-
Heron Therapeutics Announces Underwriters’ Exercise in Full of Option to Purchase Additional Shares
-
Heron Therapeutics (HRTX) Prices Offering at $12.20/Share
-
Heron Therapeutics Announces Pricing of Underwritten Public Offering of Common Stock
-
Heron Therapeutics (HRTX) to Offer $150M in Common Stock
-
Heron Therapeutics Announces Proposed Public Offering of Common Stock
-
Heron Therapeutics (HRTX) Selloff is a Buying Opportunity - Cowen
-
Cowen Remains Bullish on Heron Therapeutics (HRTX) Following HTX-011 Data and Sustol Presentation
-
Cowen Raises Price Target on Heron Therapeutics (HRTX) to $47 Following HTX-011 Analysis
-
Cowen Starts Heron Therapeutics (HRTX) at Outperform
-
Heron Therapeutics, Inc. Closes Underwritten Offering of Common Stock
-
Heron Therapeutics (HRTX) Prices 4.8M Common Offering at $24.75/Share
-
Heron Therapeutics, Inc. Announces Pricing of Underwritten Offering of Common Stock
-
Heron Therapeutics (HRTX) Plans Common Stock Offering
-
Heron Therapeutics, Inc. Announces Proposed Underwritten Offering of Common Stock

